Matches in Wikidata for { <http://www.wikidata.org/entity/Q64396079> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q64396079 description "assaig clínic" @default.
- Q64396079 description "clinical trial" @default.
- Q64396079 description "clinical trial" @default.
- Q64396079 description "clinical trial" @default.
- Q64396079 description "clinical trial" @default.
- Q64396079 description "ensaio clínico" @default.
- Q64396079 description "ensayo clínico" @default.
- Q64396079 description "ensayu clínicu" @default.
- Q64396079 description "essai clinique" @default.
- Q64396079 description "klinisch onderzoek" @default.
- Q64396079 description "клінічне випробування" @default.
- Q64396079 name "Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer" @default.
- Q64396079 type Item @default.
- Q64396079 label "Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer" @default.
- Q64396079 prefLabel "Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer" @default.
- Q64396079 P1132 Q64396079-8FB64C9B-E26A-476B-B681-E879EEC10A7A @default.
- Q64396079 P1476 Q64396079-DBCA0C11-9334-436E-8EAA-F9F957A9C91D @default.
- Q64396079 P17 Q64396079-07B1F3E5-BB43-4C08-BD9F-893AF0E610E1 @default.
- Q64396079 P2899 Q64396079-19D6B198-9037-4339-8D1E-78DEA22CB32F @default.
- Q64396079 P3098 Q64396079-BBAE2D85-3DC4-4B57-A736-B8D60005A1A9 @default.
- Q64396079 P31 Q64396079-A9149D09-915F-4610-8133-36592BB2CAD5 @default.
- Q64396079 P4844 Q64396079-3DC4DC04-6A66-4606-8C67-B6D2CB8E7B93 @default.
- Q64396079 P580 Q64396079-09F93005-DF45-4010-8BE3-2648AF4AB255 @default.
- Q64396079 P582 Q64396079-2C58EA32-4658-4CFE-AB2A-EF65E34CE8E0 @default.
- Q64396079 P6099 Q64396079-7AD7696A-1355-448D-B348-5EA6B41B8A34 @default.
- Q64396079 P8363 Q64396079-1E3077F1-172A-4261-BC8C-CCA58B78B05A @default.
- Q64396079 P859 Q64396079-CEC4F4F4-9519-4234-AB06-9D2CA81D5777 @default.
- Q64396079 P1132 "+52" @default.
- Q64396079 P1476 "A Phase IV, Multicenter, Open-Label, Single-Arm Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in First Line Treatment of Indian Patients With HER2-Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer" @default.
- Q64396079 P17 Q668 @default.
- Q64396079 P2899 "+18" @default.
- Q64396079 P3098 "NCT02445586" @default.
- Q64396079 P31 Q30612 @default.
- Q64396079 P4844 Q1998021 @default.
- Q64396079 P580 "2015-08-17T00:00:00Z" @default.
- Q64396079 P582 "2018-09-26T00:00:00Z" @default.
- Q64396079 P6099 Q42825046 @default.
- Q64396079 P8363 Q78089383 @default.
- Q64396079 P859 Q212646 @default.